Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Monsanto faces first US trial over Roundup cancer link

      Monsanto faces first US trial over Roundup cancer link

      Ruby Khatun Khatun24 Jun 2018 9:30 AM IST
      San Francisco: In the first trial of its kind, a Californian dying of cancer is suing US agrochemical giant Monsanto, claiming its popular herbicide...
      Shocking: Sensitive medical data of Andhra Pradesh residents on the web

      Shocking: Sensitive medical data of Andhra Pradesh residents on the web

      Ruby Khatun Khatun24 Jun 2018 9:30 AM IST
      HYDERABAD: Shocking!!! Sensitive medical details of patients who bought medicines from government supported generic medicine stores have been uploaded...
      Dabur sues government for denied tax sops under GST

      Dabur sues government for denied tax sops under GST

      Ruby Khatun Khatun23 Jun 2018 11:48 PM IST
      MUMBAI: Central and Uttarakhand government have been dragged to court by Dabur for rejecting tax sops for investment in poorer areas promised under...
      Fighting Malaria: Strides Shasun gets WHO pre-qualification for rectal artesunate product

      Fighting Malaria: Strides Shasun gets WHO pre-qualification for rectal artesunate product

      Ruby Khatun Khatun23 Jun 2018 4:05 PM IST
      New Delhi: Drug firm Strides Shasun said it has received pre-qualification from the World Health Organization (WHO) for its rectal artesunate product...
      Cipla gets USFDA nod for generic Testosterone Cypionate injection

      Cipla gets USFDA nod for generic Testosterone Cypionate injection

      Ruby Khatun Khatun23 Jun 2018 10:15 AM IST
      New Delhi: Drug firm Cipla said it has received the final nod from the US health regulator for generic Testosterone Cypionate injection used for...
      India for formal recognition of traditional medicines in Singapore

      India for formal recognition of traditional medicines in Singapore

      Ruby Khatun Khatun23 Jun 2018 10:00 AM IST
      Singapore: India is working towards formal recognition of traditional Indian medicines and practices in Singapore where there is a huge market, the...
      Amazon, Berkshire, JPMorgan name Atul Gawande CEO of healthcare venture

      Amazon, Berkshire, JPMorgan name Atul Gawande CEO of healthcare venture

      Ruby Khatun Khatun23 Jun 2018 9:45 AM IST
      NEW YORK: Well-regarded surgeon and author Atul Gawande, a critic of his industry’s medical practices, will lead the new company being formed by...
      Novos pioneering diabetes pill beats Victoza, Januvia in tests

      Novo's pioneering diabetes pill beats Victoza, Januvia in tests

      Ruby Khatun Khatun23 Jun 2018 9:30 AM IST
      COPENHAGEN: Novo Nordisk’s experimental diabetes pill, which it hopes will transform the diabetes market, has proved superior to both Merck & Co’s...
      Sebi will act against pharma cos in case of non-disclosure of material information, says Tyagi

      Sebi will act against pharma cos in case of non-disclosure of material information, says Tyagi

      Ruby Khatun Khatun22 Jun 2018 3:09 PM IST
      Mumbai: Markets regulator Sebi said it would take action against pharma companies if they are found not sharing information on material events like...
      AstraZeneca gets marketing permission for cancer drug in India

      AstraZeneca gets marketing permission for cancer drug in India

      Ruby Khatun Khatun22 Jun 2018 10:30 AM IST
      New Delhi: AstraZeneca Pharma India said it has received approval from the Indian drug regulator to market Durvalumab, a cancer treatment medicine, in...
      Mylan launches generic Angiomax injection

      Mylan launches generic Angiomax injection

      Ruby Khatun Khatun22 Jun 2018 10:15 AM IST
      HERTFORDSHIRE, England, and PITTSBURGH: Global pharmaceutical company Mylan N.V. announced the U.S. launch of Bivalirudin for Injection, 250 mg...
      Biocon Chief Kiran Mazumdar Shaw to deliver IISc Convocation address on June 25

      Biocon Chief Kiran Mazumdar Shaw to deliver IISc Convocation address on June 25

      Ruby Khatun Khatun22 Jun 2018 10:00 AM IST
      Bengaluru: Biocon Limited Managing Director and Chairperson Kiran Mazumdar Shaw will deliver the Convocation address of Indian Institute of Science...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok